Category

Press Release

SWHR_Logo_Final

SWHR’s 27th Annual Gala: The State of Women’s Health

By | Press Release | No Comments

FOR IMMEDIATE RELEASE:
February 2, 2017

CONTACT:
Heena Patel, Communications Director
202-223-8224
heena@swhr.org

Celebratory event honors visionary women on Wednesday, March 22 in Washington DC

WASHINGTON, DC (February 2, 2017) – The Society for Women’s Health Research (SWHR®), widely recognized as the thought-leader in promoting research on biological differences in disease, will host its 27th Annual Gala: The State of Women’s Health on Wednesday, March 22, 2017, at the Ritz-Carlton Hotel in Washington, DC.

SWHR’s Gala will host more than 400 attendees, including members of Congress; researchers and clinicians; advocacy groups and disease awareness organizations; professional, scientific and medical associations; and individuals interested in the advancement of women’s health.

This year’s gala honorees will be presented the Women’s Health Visionary Award and include:

  • Myrna Blyth, Senior Vice President and Editorial Director of AARP Media, overseeing AARP The Magazine, AARP Bulletin, AARP Studios, AARP Book Division, and the AARP Website;
  • Susan Collins, Senator from Maine, who chairs the Senate Select Committee on Aging and the Transportation, Housing, and Urban Development Appropriations Subcommittee, and also serves on the Intelligence Committee, as well as the Committee on Health, Education, Labor and Pensions; and
  • Mary Lake Polan, MD, PhD, MPH, Clinical Professor, Department of Obstetrics and Gynecology and Reproductive Sciences at Yale University School of Medicine.

“The Society for Women’s Health Research is delighted to honor Myrna Blyth, Senator Susan Collins, and Dr. Mary Lake Polan for their lifetime of exemplary leadership and commitment to professional excellence,” said Amy M. Miller, PhD, SWHR president and CEO. “These extraordinary visionaries are powerful role models who have made unique contributions in advancing women’s health.”

SWHR will also host its Second Annual Gala Symposium on March 22, 2017, which will convene some of the best minds in health policy. The symposium will feature a series of presentations on the existing challenges and important advances needed to improve the health of women of all ages. Based on this discussion, SWHR will identify strategic next steps to addressing some of the most important policy issues related to women’s health.

From its inception, SWHR has worked to further women’s health and the study of biological sex differences and continues to raise awareness of the impact of sex differences on diseases and treatment. All event proceeds will benefit SWHR’s science, advocacy, and educational programs, which ensure that women’s health remains a national priority.

Media are invited to attend the gala. To request a complimentary seat, email your name and news organization to communications@swhr.org.

###

About SWHR

The Society for Women’s Health Research (SWHR®) is a national non-profit based in Washington D.C. that is widely recognized as the thought leader in promoting research on biological differences in disease and is dedicated to transforming women’s health through science, advocacy, and education. Founded in 1990 by a group of physicians, medical researchers and health advocates, SWHR aims to bring attention to the variety of diseases and conditions that disproportionately or predominately affect women.

For more information, visit http://www.SWHR.org. Follow on Twitter at https://twitter.com/SWHR.

 

 

 

 

 

amiller

SWHR Names Amy M. Miller, PhD New Chief Executive Officer

By | Press Release | No Comments

Held Leading Post At Personalized Medicine Coalition

WASHINGTON, DC (November 22, 2016) – The Society for Women’s Health Research (SWHR®) announced the hiring of Amy M. Miller, PhD as its new Chief Executive Officer, effective January 3, 2017.

Dr. Miller leaves the Personalized Medicine Coalition (PMC), where she served as Executive Vice President, directing national programs and in particular working with innovators, scientists, providers and payors on policy issues impacting personalized medicine.

“We welcome Amy to lead SWHR at a critical crossroads in women’s health research,” said SWHR Founder Florence Haseltine, PhD, MD. “While we celebrate the many achievements in women’s health policy advocacy to date, we must continue to press for unlocking the mysteries in sex differences and how men and women are different when it comes to cures, treatments and prevention. Amy understands that, and we’re excited to invite her to lead SWHR,” said Dr. Haseltine.

Before joining PMC, Miller worked in the office of the Director of the National Institute of Mental Health, where she served as a liaison among the scientific community, the legislative branch, and the consumers of mental health care and their families. A former American Association for the Advancement of Science Fellow, she also served as a domestic policy advisor to Senator Jay Rockefeller.

Dr. Miller began her career as a researcher at the National Institute of Child Health and Human Development. Miller received a BA from the University of New Orleans and holds a doctoral degree in human development from the University of Connecticut.

“The SWHR board of directors enthusiastically welcomes Dr. Miller to SWHR, and at the same time, thanks our interim CEO Larry Hausner for his effectiveness in leading SWHR in the past year,” said SWHR Chair John J. Seng.

SWHR leads the way in advocating for greater funding for women’s health research and for the study of biological differences that affect disease; promotes the inclusion of women and minorities in medical research; pushes for the analysis of research data for sex and ethnic differences; and informs women, health care providers, and policy makers about contemporary women’s health issues.

###

ABOUT SWHR

The Society for Women’s Health Research (SWHR®) is a national non-profit based in Washington D.C. that is widely recognized as the thought leader in promoting research on biological differences in disease and is dedicated to transforming women’s health through science, advocacy, and education. Founded in 1990 by a group of physicians, medical researchers and health advocates, SWHR aims to bring attention to the variety of diseases and conditions that disproportionately or predominately affect women.

For more information, visit www.SWHR.org. Follow on Twitter at https://twitter.com/SWHR.

Screen Shot 2016-08-02 at 11.46.05 AM

DiabetesSisters and the Society for Women’s Health Research Release A Report On Women and Diabetes

By | Press Release | No Comments

Women and Diabetes: 10 Relevant Health Topics for Women Living with Diabetes, Advancing Women’s Health through Prevention, Diagnosis, Treatment and Management

DiabetesSisters and the Society for Women’s Health Research (SWHR®) have partnered to create “Women & Diabetes: 10 Relevant Health Topics for Women Living with Diabetes,” a report that aims to educate women living with diabetes, diabetes educators and healthcare providers on a variety of relevant health topics.

Edited by Aimee Gallagher, MPH, MS (SWHR) and Anna Norton, MS (DiabetesSisters), the report highlights issues specific to women living with diabetes, ranging from prevention, management, interventions and disparities, to different hormonal milestones during a woman’s lifespan.

One topic addressed in the report, Planning For A Healthy Pregnancy In Women With Type 1 Diabetes, will be presented later this month at the American Association of Diabetes Educators’ Annual Meeting in San Diego. The report’s topics, selected on a basis of importance to women and the healthcare providers and educators who interact with them, are intended to further facilitate discussions between the health and research communities and address the needs of women living with diabetes.

Supported by grants from Janssen Pharmaceuticals, Merck, and Novo Nordisk, the report brought together experts in the diabetes field including:

  • Brandy Barnes, MSW
  • Wendy L. Bennett, MD, MPH
  • Nicole M. Bereolos, PhD, MPH, CDE
  • Deborah Clegg, PhD
  • Stephen Clement, MD
  • Elizabeth (Libby) Downs, MS, RD, CDE
  • Angela F. Ford, PhD, MSW
  • Aimee M. Gallagher, MPH, MS
  • Riva Greenberg, DPE, CHC
  • Diane Herbert, CDE, MSS, LS
  • Amy Huebschmann, MD, MS, FACP
  • Monica Malampalli, PhD, MSc
  • Franck Mauvais-Jarvis, MD, PhD
  • Rhonda Merwin, PhD
  • Maria Mupanomunda, MD, PhD, MBA
  • Wanda Nicholson, MD, MPH, MBA
  • Anna Norton, MS
  • Donna Rice, MBA, RN, CDE, FAADE
  • Joshunda Sanders
  • Gary Scheiner, MS, CDE
  • Susan Weiner, MS, RDN, CDE, CDN

Experts represented various institutions including: American Diabetes Association, Black Women’s Health Imperative, Cedars-Sinai, The Johns Hopkins University, University of Colorado, and University of North Carolina at Chapel Hill.

To read the entire report, please visit: http://swhr.org/wp-content/uploads/2016/08/SWHR-Diabetes10Q_2016.pdf

 

###

About DiabetesSisters

A 501(c)(3) nonprofit, DiabetesSisters is the only organization worldwide focusing exclusively on women with diabetes. Our mission is to improve the health and quality of life of women living with and at risk of developing diabetes, and to advocate on their behalf. DiabetesSisters has a 10,000-member peer network that unites women with diabetes for the purpose of support, education, and advocacy. Signature programs include monthly small group meetings (PODS Meetups); DiabetesSisters conferences throughout the U.S.; the Life Class Webinar Series, and online blogs, forums, and expert resources. For more information, visit diabetessisters.org.

About SWHR

The Society for Women’s Health Research (SWHR®), is a national non-profit based in Washington D.C. that is widely recognized as the thought-leader in promoting research on biological differences in disease and is dedicated to transforming women’s health through science, advocacy, and education. Founded in 1990 by a group of physicians, medical researchers and health advocates, SWHR aims to bring attention to the variety of diseases and conditions that disproportionately or predominantly affect women. For more information, visit http://www.SWHR.org.  Follow us on Twitter at https://twitter.com/SWHR.

AD-Network_Web-Version

Society for Women’s Health Research Launches New Interdisciplinary Network to Focus on Sex Differences in Alzheimer’s Disease

By | Press Release | No Comments

Leading researchers, scientists, and clinicians to examine sex differences in Alzheimer’s disease with a focus on Women

Washington, D.C. (July 26, 2016) – The Society for Women’s Health Research (SWHR®), the leading voice in research on biological differences between women and men, announces the start of a new initiative focused on examining sex and gender differences in Alzheimer’s disease.

“SWHR is proud to assemble some of the best researchers in the country to examine sex differences in Alzheimer’s disease and promote policies to advance Alzheimer’s disease research. The focus on sex differences is needed to understand why the risk for Alzheimer’s disease and its progression are different in women compared to men, and to further improve our current efforts for better therapies and prevention strategies,“ said Monica Mallampalli, PhD, MSc., SWHR Vice President of Scientific Affairs.

The members of the SWHR Interdisciplinary Network on Alzheimer’s Disease will work collaboratively over the next five years to address areas of need in Alzheimer’s disease pertaining to both research and policy.

“This unique Network addresses aging and dementia, one of the most important issues facing modern societies and it does so in the context of sex differences and how they are manifested across the life course,” said Bruce McEwen, PhD, Alfred E. Mirsky Professor of Neuroscience at the Rockefeller University, Director of the Harold and Margaret Milliken Hatch Laboratory of Neuroendocrinology, member of the SWHR Board of Directors and now current member of SWHR Interdisciplinary Network on Alzheimer’s Disease. “This Network fills an important gap, as no other group is likely to do this.”

The Network officially launched following a successful introductory meeting held by SWHR on July 20, 2016. The highlights of the meeting included a review of each member’s research expertise, a discussion of Network members’ viewpoints on Alzheimer’s disease, and their thoughts on prevention and treatment, latest research advances, and evidence-based policy needs.

Click here to learn more about the Network.

###

ABOUT SWHR

The Society for Women’s Health Research (SWHR®), is a national non-profit based in Washington D.C. that is widely recognized as the thought-leader in promoting research on biological differences in disease and is dedicated to transforming women’s health through science, advocacy, and education. Founded in 1990 by a group of physicians, medical researchers and health advocates, SWHR aims to bring attention to the variety of diseases and conditions that disproportionately or predominantly affect women.

For more information, visit www.SWHR.org.  Follow us on Twitter at https://twitter.com/SWHR.

SWHR Board Chair John Seng, Founder Florence Haseltine, Ph.D, and Interim CEO Larry Hausner.

SWHR Announces Larry Hausner as Interim CEO; Names Heather Boyd Director of Public Policy

By | Press Release | No Comments

Photo: SWHR Board Chair John Seng, Founder Florence Haseltine, Ph.D, MD, and Interim CEO Larry Hausner.

 

Contact: Taylor Kuether
Phone: 202-223-8224
FOR IMMEDIATE RELEASE

SWHR Announces Larry Hausner as Interim CEO; Names Heather Boyd Director of Public Policy

WASHINGTON, D.C. (May 25, 2016) – The Society for Women’s Health Research (SWHR) announced today that non-profit health advocacy organization veteran Larry Hausner is now serving as the Society’s interim CEO. Heather Boyd, MPP, also has joined the SWHR staff as the organization’s Director of Public Policy.

“Larry’s executive leadership experience at national scale organizations such as the American Diabetes Association, Leukemia & Lymphoma Society and National Multiple Sclerosis Society manifestly equips him to guide SWHR through our directional and leadership transition process,” said SWHR Board Chair John Seng. “We also welcome Heather Boyd, who will bring her outstanding legislative and regulatory advocacy experience to work in realizing her passion for furthering women’s health research,” Seng said.

“I’ve come to appreciate SWHR’s legacy in women’s health research and effectiveness in putting the need for increased study of sex differences on the national agenda,” said Mr. Hausner. “The SWHR Board and our staff can seize new opportunities to underscore the need to expand the science behind why disease and risks to health affect women differently than men,” he said.

Helping to build SWHR’s policy presence is new Director of Public Policy Heather Boyd, MPP. Ms. Boyd comes to SWHR from the Academy of Managed Care Pharmacy, where she analyzed state legislation related to biosimilars, opioid abuse, and other managed care pharmacy issues. She brings almost a decade of policy analysis experience on a variety of healthcare issues including long-term care, pharmacy policy, and Medicare payment policy.

“Ten years ago, I moved to DC to work specifically on women’s health issues,” said Ms. Boyd. “The opportunity to advocate on behalf of women’s health is a dream come true for me. I could not be more excited to lead the advocacy efforts for women’s health research on behalf of SWHR.”

SWHR leads the way in advocating for greater funding for women’s health research and for the study of biological differences that affect disease; promote the inclusion of women and minorities in medical research; push for the analysis of research data for sex and ethnic differences; and to inform women, health care providers, and policy makers about contemporary women’s health issues.

###

ABOUT SWHR

The Society for Women’s Health Research (SWHR®), is a national non-profit based in Washington D.C. that is widely recognized as the thought-leader in promoting research on biological differences in disease and is dedicated to transforming women’s health through science, advocacy, and education. Founded in 1990 by a group of physicians, medical researchers and health advocates, SWHR aims to bring attention to the variety of diseases and conditions that disproportionately or predominately affect women.

For more information, visit www.SWHR.org.  Follow us on Twitter at https://twitter.com/SWHR.

SWHR_Logo_Final_web

Phyllis Greenberger, SWHR’s Leader For More Than Two Decades, Steps Down as President & CEO

By | Press Release | No Comments

Contact: Taylor Kuether
Phone: 202-223-8224
FOR IMMEDIATE RELEASE

Phyllis Greenberger, SWHR’s Leader For More Than Two Decades,
Steps Down as President & CEO

Earned Legacy as Leading Women’s Health Research Advocate

WASHINGTON, D.C. (May 23, 2016) – The Society for Women’s Health Research (SWHR) announced that its longtime president and CEO, Phyllis Greenberger, MSW, has decided to move on from that role.

“No one in Washington led the way to advance women’s health research over the past 25 years as did Phyllis Greenberger,” said SWHR Founder Florence Haseltine, MD, PhD. “We offer our deep gratitude to Phyllis for her passion and performance in all this time. She has guided SWHR in casting a bright light on the need to explore the scientific difference in the sexes and to advocate for the inclusion of women in clinical trials,” said Dr. Haseltine. “Anyone who knows or has worked with Phyllis has appreciated her determination to advance our understanding of the differences between the health of women and men.”

Ms. Greenberger had been president and CEO of SWHR since 1993, shortly after its founding. As a result of SWHR’s work under Ms. Greenberger’s leadership, federal mandates require the inclusion of women in medical research and clinical trials; and scientists are researching the ways in which health conditions and diseases affect men and women differently and why.

“I want to thank Florence for her vision and confidence in hiring me to lead SWHR, and acknowledge my appreciation to SWHR staff as well as thank our corporate and institutional supporters over all this time,” said Ms. Greenberger. “Together, we’ve truly made a difference in the lives of not only women but men worldwide. With so many of the milestones I set for SWHR achieved, I have decided it is time to step down from my executive and operational role with the organization. I would like to spend time on independent projects and pursue new ventures to continue bringing important insights into science that advance women’s health,” she said.

“On behalf of the entire SWHR Board of Directors, we thank Phyllis for everything she has done to advocate and help improve the health of all, through education and science advocacy in women’s health,” said SWHR Chair John Seng. “We will continue her legacy of advancing the science of sex-based biology and advocating for making a difference in people’s lives,” said Seng.

The SWHR Board of Directors is set to announce the retention of an interim CEO in the next week. Ms. Greenberger remains a member of the SWHR Board of Directors.

SWHR will continue to lead the way in advocating for greater funding for women’s health research and for the study of biological differences that affect disease; promote the inclusion of women and minorities in medical research; push for the analysis of research data for sex and ethnic differences; and to inform women, health care providers, and policy makers about contemporary women’s health issues.

###

ABOUT SWHR

The Society for Women’s Health Research (SWHR®), is a national non-profit based in Washington D.C. that is widely recognized as the thought-leader in promoting research on biological differences in disease and is dedicated to transforming women’s health through science, advocacy, and education. Founded in 1990 by a group of physicians, medical researchers and health advocates, SWHR aims to bring attention to the variety of diseases and conditions that disproportionately or predominately affect women.

For more information, visit www.SWHR.org.  Follow us on Twitter at https://twitter.com/SWHR.

briefing

Cancer Advocates Press for Swift Implementation of the Breast Cancer Patient Education Act of 2015

By | Press Release | No Comments

WASHINGTON (May 17, 2016) – Now that the number of mastectomies is increasing significantly, advocates and experts fighting for improved treatments for invasive breast cancer today called for swift action by Congress and the Obama Administration to implement the provisions of the Breast Cancer Patient Education Act of 2015 (BCPEA) so women will understand their reconstruction options at the time of diagnosis.

Assembling at a briefing on Capitol Hill, women’s health and cancer advocates celebrated BCPEA’s enactment as an important victory but urged rapid implementation because many women remain unaware about their reconstruction rights.  Accordingly, the Society for Women’s Health Research (SWHR®) urged the U.S. Congress to appropriate the funds necessary for the Department of Health and Human Services (HHS) to fulfill its responsibilities under BCPEA, which mandates a national education campaign on the availability and insurance coverage of breast reconstruction and prostheses. Since passage of the Women’s Health Care and Cancer Rights Act in 1998, health plans that offer breast cancer coverage are required to provide coverage for breast reconstruction and prostheses.

Along with action by Congress, SWHR called on HHS to take the initial steps to implement BCPEA, such as updating existing materials created by the Office of Women’s Health and the Office of Minority Health and disseminating this content through the websites of relevant federal agencies.

“Passing BCPEA, frankly, is the beginning of the journey, not the end,” said Phyllis Greenberger, MSW, President and CEO of the Society for Women’s Health Research (SWHR). “That is why we are calling for action to implement BCPEA on an expedited basis.”

Underscoring the need for BCPEA implementation, David Song, MD, MBA, FACS, President of the American Society of Plastic Surgeons (ASPS), reported that many women are unaware of their reconstruction rights, including those of racial and ethnic minorities.  This is particularly concerning for African American women under age 40 and Hispanic women who are at increased risk for invasive breast cancer.  Among the more than 230,000 women diagnosed annually with invasive breast cancer, a recent assessment from the Agency for Healthcare Research and Quality (AHRQ) finds that mastectomies increased 36% between 2005 and 2013 while the number of doubled mastectomies tripled. Yet, even with higher rates of mastectomy, ASPS puts the overall rate of breast reconstruction among these women at well below 25%.

“Today, there are many reconstruction techniques available that restore a breast to near normal shape, appearance and size following mastectomy,” Dr. Song said. “When it comes to invasive breast cancer,
women, and especially those of minority backgrounds, should not be left without proper knowledge of their reconstruction rights so they can learn about their treatment options and make informed decisions.”

-More-

Echoing the call for quick action, Tracy Posner, a patient advocate who opted for a full hysterectomy and a preventative double mastectomy after learning she has the BRCA gene mutation associated with an increased risk of developing breast and ovarian cancers, said that despite working in the medical field, trying to get answers about reconstruction can be harrowing. While she successfully underwent reconstructive surgery in 2016, Ms. Posner struggled to find adequate information to help her and is now speaking out so other women anticipating mastectomy can make the best choice for their care.

“You shouldn’t have to work in the healthcare system to have access to information about the availability and coverage of breast reconstruction options,” Ms. Posner told policymakers. “It is in everyone’s interest for women to understand their treatment options, which includes access to breast reconstruction.”

At the Congressional briefing, Debra L. Monticciolo, MD, Chair of the Commission on Breast Imaging for the American College of Radiology (ACR) and a Professor of Radiology at the Texas A&M Health Science Center, also stressed the importance of early detection through breast imaging so women will have greater treatment options and an improved chance for a full recovery.

“Breast cancer is a serious concern for all women but early detection and information on treatment options are powerful weapons for the best outcome,” said Dr. Monticciolo. “It is extremely important that women have access to thorough and understandable information on their reconstructive rights.”

The Breast Cancer Patient Education Act, which was passed on December 18, 2015 as part of omnibus spending legislation, was introduced by Representatives Leonard Lance (R-NJ) and Kathy Castor (D-FL) in the House of Representatives and Senators Roy Blunt (R-MO) and Sherrod Brown (D-OH) in the Senate. The education campaign mandated by BCPEA will inform women that breast reconstruction is possible at the time of mastectomy or after treatment is completed and if women choose not to have reconstruction, prostheses or breast forms are covered options.

About the Society for Women’s Health Research (SWHR)
The Society for Women’s Health Research (SWHR®), is a national non-profit based in Washington D.C. that is widely recognized as the thought-leader in promoting research on biological differences in disease and is dedicated to transforming women’s health through science, advocacy, and education. Founded in 1990 by a group of physicians, medical researchers and health advocates, SWHR aims to bring attention to the variety of diseases and conditions that disproportionately or predominately affect women.

For more information, visit www.SWHR.org.  Follow us on Twitter at https://twitter.com/SWHR.

About the American Society of Plastic Surgeons (ASPS)
The American Society of Plastic Surgeons is the largest plastic surgery specialty organization in the world. Founded in 1931, the society is composed of board-certified plastic surgeons that perform cosmetic and reconstructive surgery. The mission of ASPS is to advance quality care to plastic surgery patients by encouraging high standards of training, ethics, physician practice and research in plastic surgery. The Society advocates for patient safety, such as requiring its members to operate in accredited surgical facilities that have passed rigorous external review of equipment and staffing.

#####

 

050416_0020_17

The Society for Women’s Health Research Talks Revolutionizing Healthcare & Research Through Data at Annual Gala Dinner

By | Press Release | No Comments

FOR IMMEDIATE RELEASE  
May 10, 2016

Contact: Heena Patel
Phone: 202-223-8224

The Society for Women’s Health Research Talks Revolutionizing Healthcare & Research Through Data at Annual Gala Dinner

WASHINGTON, D.C. (May 10, 2016) – The Society for Women’s Health Research (SWHR®), held its annual black-tie gala May 4, 2016, this time to discuss the growing trend of big data and its impact on health, science, and medicine. More than 400 guests gathered at the Ritz-Carlton Hotel, Washington D.C., to join the conversation.

The gala featured keynote speakers Alyson J. McGregor, MD, Associate Professor of Emergency Medicine at Brown University, and David C. Page, MD, Director of Whitehead Institute, Professor of Biology, Massachusetts Institute of Technology, Investigator, Howard Hughes Medical Institute. Dr. Page presented on his work mapping the Y-chromosome and on its evolution in mammals and expression during development and was followed by a presentation by Dr. McGregor on the need for sex-specific labeling revisions and an evidence-based approach to capturing data.

Following the keynote speakers’ remarks, Kavita Patel, MD, Nonresident Senior Fellow at the Brookings Institution moderated a panel of health, science, and medical industry leaders in a discussion of changing technologies and its impact on women’s health. The panel included Robert M. Califf, MD, Commissioner of the U.S. Food and Drug Administration; Jennie Larkin, PhD, Senior Advisor for Extramural Programs and Strategic Planning at the National Institutes of Health; Anna McCollister-Slipp, Co-founder of Galileo Analytics; and Jane L. Snowdon, PhD, Director, Watson Health Partnerships, IBM.

John Seng, Founder & CEO of Spectrum and Chair of SWHR’s Board of Directors and SWHR President and CEO Phyllis Greenberger also offered remarks, noting the vital importance of data on improving the future of patient care.

“SWHR has advocated for more than 25 years for research in sex and gender differences and its impact on health and health outcomes,” said Greenberger. “However, utilizing sex differences data in clinical research is one aspect of data that holds huge promise for all patients – particularly women and minorities. We were delighted to gather such a broad group of esteemed professionals to discuss big data and what it means for the future of women’s health.”

SWHR expresses gratitude to all who attended and donated to the event, and to our generous Leadership Plus and Leadership-level sponsors: PhRMA, Allergan, Astellas, Hologic, Johnson & Johnson, Pfizer, and PWR.

###

ABOUT SWHR

The Society for Women’s Health Research (SWHR®), is a national non-profit based in Washington D.C. that is widely recognized as the thought-leader in promoting research on biological differences in disease and is dedicated to transforming women’s health through science, advocacy, and education. Founded in 1990 by a group of physicians, medical researchers and health advocates, SWHR aims to bring attention to the variety of diseases and conditions that disproportionately or predominately affect women.

 For more information, visit www.SWHR.org.  Follow us on Twitter at https://twitter.com/SWHR.

CT pic

Outcomes from SWHR’s Multi-stakeholder Workshop on Achieving Meaningful Subgroup Data in Clinical Trials Released

By | Press Release | No Comments

FOR IMMEDIATE RELEASE

March 30, 2016

CONTACT:
Leslie Ritter
202-223-8224
leslie@swhr.org

Outcomes from SWHR’s Multi-stakeholder Workshop on Achieving Meaningful Subgroup Data in Clinical Trials Released

WASHINGTON, D.C. (March 30, 2016) —The Society for Women’s Health Research (SWHR®) released the outputs of its two-day workshop “Achieving Meaningful Subgroup Data in Clinical Trial Design and Development: Scientific Approaches and Considerations.” This workshop was held in Washington D.C., on January 27-28 and included participants from academia, industry, and patient advocacy groups. SWHR convened this multi-stakeholder workshop to develop information to share with the Food and Drug Administration (FDA) and other stakeholders on:

  1. Understanding the drivers of variability in drug response among different patient populations
  2. Improving the drug development and approval process
  3. Refining communication about variability in responses to medications to patients and healthcare providers.

Meeting outputs, released in a slide deck format, include recommendations and areas of alignment among the participants and are available on SWHR’s website.

Science has shown medications work differently in diverse patient populations, meaning  medical products that may be safe and effective in some patients may be less effective or harmful in others. This has been a major concern to patient advocacy groups, industry, researchers, and the FDA.

Meeting participants were invited based on their relevant expertise and placed into teams within the three topic areas listed above. The workshop outputs were generated around questions raised in continued conversations surrounding the FDA’s 2014 Action Plan to Enhance the Collection and Availability of Subgroup Data, with the goal of providing direct feedback to the Agency.

The workshop planning committee consisted of representatives from the Biotechnology Innovation Organization, Boehringer Ingelheim Pharmaceuticals, Inc., Brigham and Women’s Hospital, Johns Hopkins School of Medicine, the Pharmaceutical Research and Manufacturers of America, Quintiles, and SWHR.

“By releasing these materials today, it is our hope that the FDA will utilize the information provided in a way that will improve and further the dialogue regarding clinical trial design and subgroup data, ” said Phyllis Greenberger, MSW, SWHR President & CEO.

“We know that biological sex, gender, racial, and ethnic differences cause variability in drug response, but we hope that having the summary information from this meeting will allow for a better discussion around improving clinical trial design and ensuring that these subgroup differences are incorporated into development and approval processes.”

The meeting materials are available on SWHR’s website.

 

###

 

About SWHR

The Society for Women’s Health Research (SWHR®), is a national nonprofit based in Washington D.C. that is widely recognized as the thought-leader in promoting research on biological differences in disease and is dedicated to transforming women’s health through science, advocacy, and education. Founded in 1990 by a group of physicians, medical researchers and health advocates, SWHR aims to bring attention to the variety of diseases and conditions that disproportionately or predominately affect women.

For more information, visit www.SWHR.org. Follow us on Twitter at https://twitter.com/SWHR.

SWHR 26th Annual Gala Website Banner

SWHR’s 26th Annual Gala: “Revolutionizing Healthcare & Research Through Data”

By | Press Release | No Comments

CONTACT:
Heena Patel
202-223-8224
heena@swhr.org

FOR IMMEDIATE RELEASE
March 1, 2016

SWHR’s 26th Annual Gala:
“Revolutionizing Healthcare & Research Through Data”

WASHINGTON, D.C. (March 1, 2016) – The Society for Women’s Health Research (SWHR®) will host its 26th annual gala on Wednesday, May 4, 2016 at The Ritz-Carlton Hotel in Washington, D.C.

This year’s signature event, “Revolutionizing Healthcare & Research Through Data,” will explore big data’s impact on the future of health, science, and medicine.

Data initiatives are revolutionizing healthcare and helping to improve every aspect of medicine, from bench to bedside. This data, which is being collected and utilized by healthcare providers, pharmaceutical and medical device companies, insurance companies, hospitals, and researchers, provides a wealth of healthcare information that can be used to better inform healthcare decisions and delivery for every woman.

Extensive advances in data generation and collection are changing the way we visit and interact with healthcare providers.  Even on an individual level, people are collecting their personal health data through “wearables” that monitor weight, diet, exercise, heart and metabolic rates, sleep, and more.

Join usas we discuss how the healthcare community can move beyond conversation to an era of personalized care.

Keynote speakers Alyson J. McGregor, MD, Associate Professor of Emergency Medicine at Brown University and David C. Page, MD, Director of the Whitehead Institute and Professor of Biology at Massachusetts Institute of Technology and

Investigator at Howard Hughes Medical Institute will lead the conversation on how data is advancing health and medicine.

The evening also will feature a panel discussion moderated by Kavita Patel, MD, Nonresident Senior Fellow at the Brookings Institution. Panelists include Philip E. Bourne, PhD, Associate Director for Data Science at the NIH; Robert M. Califf, MD, FDA Commissioner; Anna McCollister-Slipp, Co-founder of Galileo Analytics; and Jane L. Snowdon, PhD, Director, Watson Health Partnerships, IBM.

All event proceeds will benefit SWHR’s science, advocacy and educational programs, which ensure that women’s health remains a national priority.

Media are invited to attend the gala. To request a complimentary seat, email your name and news organization to communications@swhr.org.

###

About SWHR

The Society for Women’s Health Research (SWHR®), is a national non-profit based in Washington D.C. that is widely recognized as the thought-leader in promoting research on biological differences in disease and is dedicated to transforming women’s health through science, advocacy, and education. Founded in 1990 by a group of physicians, medical researchers and health advocates, SWHR aims to bring attention to the variety of diseases and conditions that disproportionately or predominately affect women.  

For more information, visit www.SWHR.org. Follow us on Twitter at https://twitter.com/SWHR.

Social media & sharing icons powered by UltimatelySocial